IMS Health announced Thursday it has entered into a definitive agreement to be acquired by investment funds managed by TPG Capital and the CPP Investment Board in a transaction with a total value of $5.2 billion, including the assumption of debt.
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
The Board of Directors of IMS Health (NYSE: RX) today declared a regular fourth-quarter 2009 dividend of $0.03 per share, payable on December 4, 2009 to shareholders of record at the close of business on November 6, 2009.
Track · email · face · Twitter · digg · COMMENTS
by Larry Etter
Advertisement